MGH Bipolar CHOICE trial to evaluate effectiveness of new medications compared to lithium

Published January 23, 2011

MGH Bipolar CHOICE trial to evaluate effectiveness of new medications compared to lithium
The Massachusetts General Hospital (MGH) Bipolar Clinic and Research Program with the Bipolar Trials Network is launching Bipolar CHOICE, a 10-site nationwide trial evaluating the real-world advantages and disadvantages of quetiapine, a widely prescribed second generation antipsychotic mood stabilizing medication, compared to lithium, the gold standard mood stabilizer, for the treatment of …
Read more on News-Medical-Net

After Tucson shooting, cuts in mental health programs scrutinized
TUCSON, Ariz. — Unlike many of her fellow governors, Jan Brewer of Arizona knows well the inner workings of her state’s mental health system: Her son has schizophrenia and was committed to a state hospital more than 20 years ago after being found not guilty by reason of insanity of sexual assault and kidnapping.
Read more on Pioneer Press

Spelling out the pluses of the ABC System
With the General Assembly returning to town later this month and a budget deficit looming, the public debate over the future of the state’s ABC system will most likely intensify.
Read more on The News & Observer